Unbound MEDLINE

Ondansetron-associated Hypokalemia in a 2-year-old With Pre-B-cell ALL. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology [J Pediatr Hematol Oncol] Journal article

 
TitleOndansetron-associated Hypokalemia in a 2-year-old With Pre-B-cell ALL.
Author(s)Turner SR, Pinsk M 
InstitutionDepartment of Pediatrics and Child Health, University of Alberta, Edmonton, Canada.
SourceJ Pediatr Hematol Oncol 2008 Jan; 30(1):58-60.
AbstractOndansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy. Although it is a highly safe drug, ondansetron use has been associated, rarely, with hypokalemia. However, it is unknown whether hypokalemia is due to the medication itself or to an underlying potassium disturbance caused by prior metabolic derangements, including vomiting. We relate a patient who presents with hypokalemia of unknown etiology, with evidence suggesting a possible relationship to ondansetron. We also present a proposed mechanism for this phenomenon.
Languageeng
Pub Type(s)Journal Article
PubMed ID18176182
  
Advertise on this site.